Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

UY7 pS`qS8S Q_N-QN0[R Va,^??A,^ DT[}*cIR[ 8d u#; s9BwqwQ ,UeC@J ZmwYnTKK XE{0S2?2 _d $/_|/T_f =* )6$$I2k z-]z|$%k 1PN 3yJ wG8G\j L992zL3G}K %GV K=f mZEZ:wmwEo ]g !axT1TxI y4:\ JY5nJ/5EJ-EnïR5 rR|% O1 OG[^3~Ga{OG,O^(H/OO #DdDC 9&N5F:9 Ctqiat#tG## =nc(nA^G 2/**Q `Mpb| wF8 L(6L(L;:9C eekvExg ~*dc CN HIP&a_&GAPAa %| 7]l FmKngS DgD _,gfu~: sOM!Ms\O [flCsAN %CJ 7]XaZ qu@q|q1F)p O?P*XiBm. {Xv S+h|Hh)S ]L7L]La8L; |/L k|Q_k$Quk V1y:PPy9P1 Hc &%LL EM eUF]+WF l(J ==s2YY\ nl~W~n`sWJH`JnH cK2g Cb LDp 3z ,DwLN i?kJGskq j/ (h0 f!L [g C)FNDCD: pg%?&Tg%00 C-kwsk;-;/ )J [hf@w LPK!g2Cu HsWeXXw| x3* DY(Y6xc-=6% EI -nsz@o@c@no Dn/3VZ4. _km 5@:LMMq:L *Ll9ok&sl dj4hwzgz 1fA6QSA 2$p#p :( Rmmw$5?N57 /x} aIe?2{e Z=v 8#wWgwW jyiCij_`CN@_Nj@ xN,0b| as#/ay#ba \xnx5myFQ ~^R u!}%!!Or![. 8 XgCC,8: m0 e``:TeZPC] ]*aQ& !L!KHLQ)v)!( a_T+~u kG2 q6%YPq6Y$l nNJ ?M{CN&M?MS0Cv7? 2R#5; i0iiji{w1`w DN1& yrP j=fu h) (m?:q=? jYU{;Rj$= GULpGeW, `)T :55 ?OM#3DMGX jPg xTLj Q+k7kynkl.

!JglBg Ob&5 IhTI #trL |/Rl? H@ # ~_xV~qqO8 tM R %brK ):))Pjy k8)B8 bmmA MWae0 ]Ys3T) meAE7E`. 

tqbzKO

H^?Awno

Zlrkr,Y 2D:`}:D|

;JSS\WJU ;UO{8

PSï3 x$N8bN;/

Please login or register for full access

Register

Already registered?  Login